Dr. Rompas advises biopharmaceutical companies on how to best formulate and execute commercial strategies across the product lifecycle. In leading global strategic engagements, Dr. Rompas specializes in quantitative pricing analysis, the dynamics of the global reimbursement / funding environment, generic competition, and models of commercialization risk. Prior to joining Boston Healthcare, Dr. Rompas worked as a Senior Consultant at GfK Bridgehead, and he began his career at IMS Consulting Group in the Price & Market Access practice. He has chaired and presented world-leading empirical research on explaining trends of resource acquisition under technological uncertainty, and is a member of the Strategic Management Society.
Dr. Rompas received a PhD in Corporate Strategy from Warwick Business School, where he was an Economic and Social Research Council (ESRC) Fellow, and an MSc in International Health Management from Imperial College London.